This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Clinical features

Authoring team

Possible features of Duchenne's muscular dystrophy appear in the first five years of life and consist of:

  • delayed walking - after 18 months
  • not running by age 3
  • frequent falls
  • lordotic waddling gait
  • difficulty in climbing stairs
  • Gower's sign
  • weakness is symmetrical:
    • iliopsoas, gluteal and quadriceps are affected first
    • then, pretibial muscles
    • then, pectoral and shoulder girdle
  • wasting of most affected muscles
  • pseudohypertrophy of the calves
  • muscle pain or cramps or calf hypertrophy
  • episodes of myoglobinuria (cola coloured urine)
  • unexplained raised levels of lactate dehydrogenase or aminotransferases (ALT or AST)
  • learning difficulties and behavioural issues
  • speech and language delay
  • autistic spectrum disorder

Cardiac and respiratory complications are seen, especially with disease progression, and if untreated DMD typically leads to death in the late teens (1).

Multidisciplinary care, particularly the initiation of corticosteroids and assisted ventilation supported by regular cardiac and respiratory monitoring, has led to increasing numbers of patients living into adulthood in recent years

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.